28. According to the Institute for Safe Medication Practices ISMP which of the following drug classes is considered high-alert in a community pharmacy setting?
Answer: D
Injectable insulins are considered high-alert in a community pharmacy setting.
Injectable insulins fall under the high-alert drug classes due to their potential to cause significant harm if used incorrectly, highlighting the critical need for careful handling and dispensing in community pharmacies.
A) Otic suspensions
Otic suspensions are typically used for ear-related conditions and are not classified as high-alert medications. While they require proper administration to avoid complications, they generally do not carry the same risk level as injectable insulins.
B) Oral antibiotic tablets
Oral antibiotic tablets are important for treating infections but are not considered high-alert medications. They have a lower risk profile compared to injectable insulins and do not require the same stringent measures for safe dispensing in a pharmacy setting.
C) Transdermal patches
Transdermal patches can present challenges in dosing and administration but are not classified as high-alert drugs. The risk associated with transdermal patches is less acute than that of injectable insulins, which can lead to severe consequences if mismanaged.
D) Injectable insulins
Injectable insulins are classified as high-alert medications because improper dosing or administration can lead to life-threatening hypoglycemia or hyperglycemia. This classification underscores the necessity for pharmacists to exercise heightened caution and vigilance when dispensing these drugs.
Conclusion
Injectable insulins are rightly regarded as high-alert medications due to the serious health risks associated with their misuse. In contrast, otic suspensions, oral antibiotic tablets, and transdermal patches do not carry the same level of risk, making them less critical in terms of safety measures in community pharmacy settings. This distinction emphasizes the importance of awareness and careful handling of injectable insulins in pharmacy practice.